VERV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 19.30%

Insider Buying (Last 12 Months): $475,760.00

Insider Selling (Last 12 Months): $25,427.05

Verve Therapeutics Insider Trading History Chart

Verve Therapeutics Share Price & Price History

^$3.85

▼ -0.06 (-1.53%)

As of 04/3/2025 05:00 PM ET

Days: 30 | 90 | 365

Verve Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2025	Allison Dorval	CFO	Sell	3,350	$4.15	$13,902.50	13,280
4/2/2025	Joan Nickerson	Insider	Sell	2,777	$4.15	$11,524.55	17,420
5/14/2024	Andrew D. Ashe	Insider	Buy	76,000	$6.26	$475,760.00	342,509
4/2/2024	Joan Nickerson	Insider	Sell	1,514	$8.24	$12,475.36	8,659
11/29/2023	Allison Dorval	CFO	Sell	554	$11.45	$6,343.30	4,060
12/1/2022	Andrew Bellinger	CMO	Sell	865	$22.95	$19,851.75	6,629
11/29/2022	Allison Dorval	CFO	Sell	554	$22.10	$12,243.40	2,186
11/4/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	97,166	$31.14	$3,025,749.24
11/3/2022	Krishna Yeshwant	Director	Sell	49,568	$32.79	$1,625,334.72	4,308,630
11/2/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	57,303	$35.94	$2,059,469.82
10/31/2022	2017 Gp L.L.C. Gv	Major Shareholder	Sell	107,393	$38.64	$4,149,665.52
10/31/2022	Krishna Yeshwant	Director	Sell	53,696	$38.64	$2,074,813.44	4,418,813
10/28/2022	Andrew Bellinger	CMO	Sell	10,000	$39.90	$399,000.00	6,629
10/3/2022	Sekar Kathiresan	CEO	Sell	50,000	$33.65	$1,682,500.00	317,839
9/23/2022	Andrew Bellinger	CMO	Sell	60,000	$35.34	$2,120,400.00	6,629
8/10/2022	Sekar Kathiresan	CEO	Sell	50,000	$29.90	$1,495,000.00	317,839
7/20/2022	Andrew Bellinger	CMO	Sell	20,000	$34.90	$698,000.00	6,629
7/19/2022	Sekar Kathiresan	CEO	Sell	50,000	$29.90	$1,495,000.00	317,839
7/13/2022	Andrew Bellinger	CMO	Sell	10,000	$24.90	$249,000.00	6,629
7/12/2022	Fmr Llc	Insider	Sell	163,000	$20.78	$3,387,140.00	570,729
7/1/2022	Fmr Llc	Insider	Sell	38,775	$15.66	$607,216.50	773,729
6/29/2022	Fmr Llc	Insider	Sell	34,409	$15.59	$536,436.31	791,314
5/12/2022	Burt A. Adelman	Director	Buy	10,000	$12.15	$121,500.00	18,700

See Full Table

SEC Filings (Institutional Ownership Changes) for Verve Therapeutics (NASDAQ:VERV)

97.11% of Verve Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Verve Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	361,498	$2.04M	0.0%	+4.2%	0.407%
3/18/2025	California State Teachers Retirement System	63,500	$0.36M	0.0%	+12.5%	0.072%
2/19/2025	Public Employees Retirement System of Ohio	106,356	$0.60M	0.0%	+81.2%	0.126%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	119,818	$0.68M	0.0%	+4.2%	0.142%
2/17/2025	Vestal Point Capital LP	645,000	$3.64M	0.2%	+22.9%	0.762%
2/17/2025	Two Sigma Advisers LP	293,200	$1.65M	0.0%	+58.8%	0.346%
2/17/2025	Two Sigma Investments LP	570,304	$3.22M	0.0%	+32.5%	0.674%
2/17/2025	Tema Etfs LLC	89,239	$0.50M	0.2%	N/A	0.105%
2/17/2025	Rafferty Asset Management LLC	136,417	$0.77M	0.0%	-35.3%	0.161%
2/17/2025	Redmile Group LLC	1,318,164	$7.43M	0.5%	-4.7%	1.557%
2/17/2025	Point72 Asset Management L.P.	1,394,116	$7.86M	0.0%	N/A	1.647%
2/17/2025	ProShare Advisors LLC	24,016	$0.14M	0.0%	+30.4%	0.028%
2/17/2025	Nuveen Asset Management LLC	1,315,771	$7.42M	0.0%	-21.3%	1.554%
2/17/2025	Millennium Management LLC	3,919,131	$22.10M	0.0%	-22.0%	4.629%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	144,749	$0.82M	0.0%	+16.5%	0.171%
2/17/2025	Jacobs Levy Equity Management Inc.	1,848,071	$10.42M	0.0%	+18.5%	2.183%
2/17/2025	Graham Capital Management L.P.	40,420	$0.23M	0.0%	-44.0%	0.048%
2/17/2025	Fiduciary Trust Co	60,000	$0.34M	0.0%	+20.0%	0.071%
2/17/2025	D. E. Shaw & Co. Inc.	37,984	$0.21M	0.0%	N/A	0.045%
2/17/2025	Deutsche Bank AG	64,909	$0.37M	0.0%	+55.7%	0.077%
2/17/2025	Cubist Systematic Strategies LLC	117,600	$0.66M	0.0%	-82.7%	0.139%
2/17/2025	BVF Inc. IL	6,904,050	$38.94M	1.3%	+962.2%	8.155%
2/17/2025	Balyasny Asset Management L.P.	85,116	$0.48M	0.0%	+100.7%	0.101%
2/17/2025	Bank of America Corp DE	547,671	$3.09M	0.0%	-29.4%	0.647%
2/17/2025	BNP Paribas Financial Markets	8,876	$50K	0.0%	N/A	0.010%
2/17/2025	Ameriprise Financial Inc.	258,873	$1.46M	0.0%	+14.5%	0.306%
2/17/2025	Algert Global LLC	188,005	$1.06M	0.0%	-16.2%	0.222%
2/17/2025	Acuta Capital Partners LLC	160,200	$0.90M	0.9%	+9.7%	0.189%
2/14/2025	PDT Partners LLC	53,291	$0.30M	0.0%	-70.7%	0.063%
2/14/2025	Schonfeld Strategic Advisors LLC	3,789,379	$21.37M	0.1%	+57.4%	4.476%
2/14/2025	Northern Trust Corp	650,562	$3.67M	0.0%	+12.7%	0.768%
2/14/2025	Boothbay Fund Management LLC	53,317	$0.30M	0.0%	+7.2%	0.063%
2/14/2025	Susquehanna Fundamental Investments LLC	291,383	$1.64M	0.0%	N/A	0.344%
2/14/2025	Virtus ETF Advisers LLC	11,411	$64K	0.0%	-30.7%	0.013%
2/14/2025	Voya Investment Management LLC	22,161	$0.13M	0.0%	-6.5%	0.026%
2/14/2025	Syon Capital LLC	53,469	$0.30M	0.0%	N/A	0.063%
2/14/2025	T. Rowe Price Investment Management Inc.	2,352,599	$13.27M	0.0%	-3.0%	2.779%
2/14/2025	Price T Rowe Associates Inc. MD	28,998	$0.16M	0.0%	-27.7%	0.034%
2/14/2025	Dark Forest Capital Management LP	21,416	$0.12M	0.0%	-23.9%	0.025%
2/14/2025	Stifel Financial Corp	141,142	$0.80M	0.0%	+7.4%	0.167%
2/14/2025	Tower Research Capital LLC TRC	13,397	$76K	0.0%	-49.0%	0.016%
2/14/2025	Dimensional Fund Advisors LP	437,089	$2.47M	0.0%	+1.2%	0.516%
2/13/2025	Jump Financial LLC	147,819	$0.83M	0.0%	+26.2%	0.175%
2/13/2025	Barclays PLC	220,731	$1.24M	0.0%	-1.0%	0.261%
2/13/2025	Renaissance Technologies LLC	363,400	$2.05M	0.0%	-36.8%	0.429%
2/13/2025	Legal & General Group Plc	64,426	$0.36M	0.0%	+15.4%	0.076%
2/13/2025	Invesco Ltd.	57,140	$0.32M	0.0%	+5.7%	0.067%
2/13/2025	Bank of Montreal Can	44,139	$0.25M	0.0%	-12.2%	0.052%
2/13/2025	Russell Investments Group Ltd.	76,038	$0.43M	0.0%	-27.9%	0.090%
2/13/2025	Wells Fargo & Company MN	45,422	$0.26M	0.0%	+25.0%	0.054%
2/12/2025	Trexquant Investment LP	635,847	$3.59M	0.0%	+14.5%	0.751%
2/12/2025	Geode Capital Management LLC	1,625,780	$9.17M	0.0%	+1.6%	1.920%
2/12/2025	Alliancebernstein L.P.	74,000	$0.42M	0.0%	-11.3%	0.087%
2/12/2025	Wellington Management Group LLP	361,498	$2.04M	0.0%	+4.2%	0.427%
2/12/2025	Norges Bank	78,186	$0.44M	0.0%	N/A	0.092%
2/12/2025	JPMorgan Chase & Co.	417,539	$2.36M	0.0%	-74.7%	0.493%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	50,230	$0.31M	0.0%	+5.8%	0.059%
2/11/2025	Corebridge Financial Inc.	35,320	$0.20M	0.0%	-7.0%	0.042%
2/11/2025	Vanguard Group Inc.	4,006,634	$22.60M	0.0%	+0.0%	4.733%
2/11/2025	LPL Financial LLC	37,629	$0.21M	0.0%	+94.5%	0.044%
2/11/2025	KLP Kapitalforvaltning AS	17,900	$0.10M	0.0%	N/A	0.021%
2/11/2025	American Century Companies Inc.	127,464	$0.72M	0.0%	+12.3%	0.151%
2/11/2025	Teacher Retirement System of Texas	20,254	$0.11M	0.0%	+37.4%	0.024%
2/10/2025	Commonwealth Equity Services LLC	31,952	$0.18M	0.0%	+17.6%	0.038%
2/10/2025	Swiss National Bank	133,100	$0.75M	0.0%	+15.6%	0.157%
2/7/2025	HighTower Advisors LLC	20,428	$0.12M	0.0%	N/A	0.024%
2/6/2025	Arizona State Retirement System	19,593	$0.11M	0.0%	+15.8%	0.023%
2/6/2025	Charles Schwab Investment Management Inc.	570,718	$3.22M	0.0%	-0.3%	0.674%
2/5/2025	US Bancorp DE	30,616	$0.17M	0.0%	+62.8%	0.036%
2/4/2025	Los Angeles Capital Management LLC	231,123	$1.30M	0.0%	-11.9%	0.273%
2/4/2025	Bank of New York Mellon Corp	220,502	$1.24M	0.0%	+2.4%	0.260%
2/4/2025	IFP Advisors Inc	8,238	$47K	0.0%	+823,700.0%	0.010%
1/30/2025	Rhumbline Advisers	111,203	$0.63M	0.0%	+1.9%	0.131%
1/24/2025	China Universal Asset Management Co. Ltd.	17,952	$0.10M	0.0%	+10.3%	0.021%
1/21/2025	Impact Partnership Wealth LLC	12,466	$70K	0.0%	N/A	0.015%
1/17/2025	Nisa Investment Advisors LLC	42,781	$0.24M	0.0%	+465.4%	0.051%
1/13/2025	Green Alpha Advisors LLC	29,438	$0.17M	0.1%	+15.0%	0.035%
1/10/2025	Harbor Capital Advisors Inc.	41,544	$0.23M	0.0%	-22.4%	0.049%
1/3/2025	GAMMA Investing LLC	6,054	$34K	0.0%	+189.7%	0.007%
12/26/2024	JPMorgan Chase & Co.	1,647,844	$7.98M	0.0%	-2.6%	1.946%
11/27/2024	Franklin Resources Inc.	34,155	$0.17M	0.0%	+20.9%	0.040%
11/19/2024	Barclays PLC	222,919	$1.08M	0.0%	+139.8%	0.263%
11/16/2024	Geode Capital Management LLC	1,600,687	$7.75M	0.0%	+2.6%	1.891%
11/15/2024	Barclays PLC	222,919	$1.08M	0.0%	+139.8%	0.263%
11/15/2024	Public Employees Retirement System of Ohio	58,700	$0.28M	0.0%	+27.3%	0.069%
11/15/2024	XTX Topco Ltd	103,348	$0.50M	0.0%	N/A	0.122%
11/15/2024	Wellington Management Group LLP	347,029	$1.68M	0.0%	-6.5%	0.410%
11/15/2024	State Street Corp	4,253,217	$20.59M	0.0%	+27.0%	5.024%
11/15/2024	Stifel Financial Corp	131,406	$0.64M	0.0%	+14.7%	0.155%
11/15/2024	Redmile Group LLC	1,383,366	$6.70M	0.4%	-5.5%	1.634%
11/15/2024	Point72 DIFC Ltd	17,143	$83K	0.0%	N/A	0.020%
11/15/2024	Ikarian Capital LLC	170,000	$0.82M	0.1%	N/A	0.201%
11/15/2024	Jacobs Levy Equity Management Inc.	1,559,393	$7.55M	0.0%	+72.2%	1.842%
11/15/2024	Erste Asset Management GmbH	11,300	$56K	0.0%	N/A	0.013%
11/14/2024	PFM Health Sciences LP	125,999	$0.61M	0.0%	N/A	0.149%
11/14/2024	PDT Partners LLC	181,803	$0.88M	0.1%	-45.5%	0.215%
11/14/2024	Braidwell LP	623,980	$3.02M	0.1%	N/A	0.737%
11/14/2024	Verition Fund Management LLC	28,714	$0.14M	0.0%	N/A	0.034%
11/14/2024	Vestal Point Capital LP	525,000	$2.54M	0.2%	+5.0%	0.620%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	115,041	$0.56M	0.0%	+6.1%	0.136%

Data available starting January 2016

See Full Table

Verve Therapeutics, Inc., a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver; and VERVE-102, a product candidate that targets the PCSK9 gene for the treatment of HeFH. It engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $3.85

$3.68

$3.96

50 Day Range

MA: $6.70

$3.85

$8.63

52 Week Range

Now: $3.85

$3.68

$9.31

Volume

2,477,105 shs

Average Volume

1,426,210 shs

Market Capitalization

$341.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Who are the company insiders with the largest holdings of Verve Therapeutics?: Verve Therapeutics' top insider investors include:
Andrew D Ashe (Insider)
Joan Nickerson (Insider)
Allison Dorval (CFO)
Learn More about top insider investors at Verve Therapeutics.